Treatment of atrial flutter
31 results
1 - 31
Treatment of atrial flutter 
External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta‐analysis- Electrical cardioversion for atrial fibrillation and flutter: Cochrane systematic review
- Pharmacological cardioversion for atrial fibrillation and flutter: Cochrane systematic review
Atrial fibrillation recurrence higher with episodic treatment with amiodarone- Concomitant atrial fibrillation surgery for people undergoing cardiac surgery
- Differential diagnosis of broad complex tachycardia
- Prevention of atrial fibrillation
- Electrical cardioversion
- Vitamin D and/or fish oil supplementation do not reduce the risk of atrial fibrillation (VITAL)
- Indications for and implementation of anticoagulant therapy in atrial fibrillation
- Symptoms of arrhythmia and examination of an arrhythmia patient
- Management of acute atrial fibrillation
- Epidural analgesia for adults undergoing cardiac surgery with or without cardiopulmonary bypass
- Supraventricular tachycardia (SVT)
- Dilated cardiomyopathy
- Warfarin provides greater net benefit than rivaroxaban for patients with atrial fibrillation and rheumatic heart disease
- Rivaroxaban is noninferior to warfarin for valvular atrial fibrillation; also associated with fewer strokes
- Direct oral anticoagulants associated with better outcomes than warfarin in older patients with stroke and AF (PROSPER)
- Factor Xa inhibitors versus vitamin K antagonists for preventing embolism in patients with atrial fibrillation
- Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents
- Direct oral anticoagulants versus vitamin K antangonists in non-valvular atrial fibrillation
- Cardiac pacemakers and monitoring their function
- Dyspnoea
- Prehospital emergency care